Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology

Merck, known as MSD outside of the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational class of engineered circular RNA (oRNA) therapies, announced a collaboration agreement to discover, develop and commercialize multiple programs, including vaccines and therapeutics in the areas of infectious disease and oncology. Read more.